Heidi Health expands beyond AI scribe with UK acquisition
Melbourne’s Heidi Health is betting that winning the AI scribe race won’t be enough — and the real prize is becoming the layer across the entire clinical encounter.
Melbourne-based Heidi Health started as an AI scribe — a tool that sits in a doctor’s consultation, transcribes the conversation, and generates clinical notes. It’s a crowded space, with dozens of competitors racing to embed themselves into GP and hospital workflows. But co-founder and CEO Thomas Kelly has never seen the scribe as the destination.
This week, the company launched two new products and acquired a UK clinical AI startup, signalling it’s ready to move well beyond note-taking.
The new releases are Heidi Evidence, a clinical research tool built in partnership with EMGuidance and NICE Guidelines, and Heidi Comms, which handles patient scheduling and communication.
The acquisition — UK company Automedica, founded by two vascular surgeons — brings in technology to make AI-generated clinical evidence reliable enough to use at the point of care.
